These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32218774)

  • 1. BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny.
    Angelidou A; Diray-Arce J; Conti MG; Smolen KK; van Haren SD; Dowling DJ; Husson RN; Levy O
    Front Microbiol; 2020; 11():332. PubMed ID: 32218774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.
    Angelidou A; Conti MG; Diray-Arce J; Benn CS; Shann F; Netea MG; Liu M; Potluri LP; Sanchez-Schmitz G; Husson R; Ozonoff A; Kampmann B; van Haren SD; Levy O
    Vaccine; 2020 Feb; 38(9):2229-2240. PubMed ID: 32005538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
    Fritschi N; Curtis N; Ritz N
    Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    Guerra-Maupome M; Vang DX; McGill JL
    PLoS One; 2019; 14(2):e0212751. PubMed ID: 30794653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
    Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
    Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the BCG vaccine and other approaches toward tuberculosis eradication.
    Cho T; Khatchadourian C; Nguyen H; Dara Y; Jung S; Venketaraman V
    Hum Vaccin Immunother; 2021 Aug; 17(8):2454-2470. PubMed ID: 33769193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C)-Encapsulating Nanoparticles Enhance Innate Immune Responses to the Tuberculosis Vaccine Bacille Calmette-Guérin (BCG) via Synergistic Activation of Innate Immune Receptors.
    Speth MT; Repnik U; Müller E; Spanier J; Kalinke U; Corthay A; Griffiths G
    Mol Pharm; 2017 Nov; 14(11):4098-4112. PubMed ID: 28974092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Newborn Monocytes Demonstrate Distinct BCG-Induced Primary and Trained Innate Cytokine Production and Metabolic Activation
    Angelidou A; Diray-Arce J; Conti MG; Netea MG; Blok BA; Liu M; Sanchez-Schmitz G; Ozonoff A; van Haren SD; Levy O
    Front Immunol; 2021; 12():674334. PubMed ID: 34326836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccination induces cross-protective immunity against pathogenic microorganisms.
    Soto JA; Gálvez NMS; Andrade CA; Ramírez MA; Riedel CA; Kalergis AM; Bueno SM
    Trends Immunol; 2022 Apr; 43(4):322-335. PubMed ID: 35074254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress in the off-target effects of Bacille Calmette-Guérin vaccine.
    Wu Y; Zhang X; Zhou L; Lu J; Zhu F; Li J
    Chin Med J (Engl); 2024 Sep; 137(17):2065-2074. PubMed ID: 38092722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
    Martín C; Marinova D; Aguiló N; Gonzalo-Asensio J
    Vaccine; 2021 Dec; 39(50):7277-7285. PubMed ID: 34238608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the BCG vaccine and its future scope.
    Khandelia P; Yadav S; Singh P
    Indian J Tuberc; 2023; 70 Suppl 1():S14-S23. PubMed ID: 38110255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations.
    Uthayakumar D; Paris S; Chapat L; Freyburger L; Poulet H; De Luca K
    Front Immunol; 2018; 9():2869. PubMed ID: 30564249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against
    Ning H; Kang J; Lu Y; Liang X; Zhou J; Ren R; Zhou S; Zhao Y; Xie Y; Bai L; Zhang L; Kang Y; Gao X; Xu M; Ma Y; Zhang F; Bai Y
    Front Immunol; 2022; 13():943667. PubMed ID: 36081510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.